SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-052289
Filing Date
2023-02-28
Accepted
2023-02-28 08:01:05
Documents
14
Period of Report
2023-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d297639d8k.htm   iXBRL 8-K 32029
2 EX-99.1 d297639dex991.htm EX-99.1 12734
6 GRAPHIC g297639dsp6.jpg GRAPHIC 7195
  Complete submission text file 0001193125-23-052289.txt   188868

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tngx-20230227.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20230227_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20230227_pre.xml EX-101.PRE 11708
8 EXTRACTED XBRL INSTANCE DOCUMENT d297639d8k_htm.xml XML 3467
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 23678463
SIC: 2834 Pharmaceutical Preparations